ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

Experts Raise Questions About Influential Swedish Trial Of Mammography Screening.

May 11, 2007

DCT Issues New Program Announcement On Clinical Research

December 5, 1980

NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen

May 27, 1983

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994